Ursprung des Netzwerks ersten Grades von Matthias Klaften
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
amcure GmbH
 amcure GmbH BiotechnologyHealth Technology amcure GmbH develops active ingredients for the treatment of angiogenesis-related diseases. It offers a peptide based substance, that targets the tumor specific co-receptors. The company was founded by Matthias Klaften and Alexandra Matzke on December 14, 2011 and is headquartered in Eggenstein-Leopoldshafen, Germany.
3
| Holding Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Matthias Klaften
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree |
Statistik
International
| Deutschland | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Founder | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Klaus Dembowsky | 6 |
| Alexandra Matzke | 1 |
| Silvia Giordano | 1 |
- Börse
- Insiders
- Matthias Klaften
- Unternehmensverbindungen
